People
Abeona Therapeutics names Carsten Thiel new chief executive officer
23 April 2018 -

Abeona Therapeutics, a rare genetic disease focused biopharma, has named Carsten Thiel as its new chief executive officer, it was reported on Friday.

Thiel, who was formerly serving as the company's executive vice president and chief commercial officer, brings experience in leading commercial operations to his new position. Following a 25-year career in the biopharmaceutical industry, Thiel has held numerous roles for several biopharma's including Amgen and Roche.

Steven Rouhandeh, executive chairman of Abeona, said, 'As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona. In his recent positions, he successfully created value by building cohesive talented teams, driving the commercial success of multiple products globally and fostering entrepreneurial culture; all key aspects that will be critical to our success in these areas in the years ahead.'

Login
Username:

Password: